<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01643616</url>
  </required_header>
  <id_info>
    <org_study_id>HV 2010 003</org_study_id>
    <nct_id>NCT01643616</nct_id>
  </id_info>
  <brief_title>Ultrasound Guided Distal Sciatic Nerve Block - a Comparison With Nerve Stimulator Technique</brief_title>
  <official_title>Ultrasound Guided Distal Sciatic Nerve Block - a Randomised Comparison With Nerve Stimulator Technique</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helios Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Helios Research Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      For distal sciatic nerve block this prospective, randomised comparison with ultrasound guided
      distal subepineural block tested the hypothesis, that intraepineural injection of local
      anesthetic using nerve stimulation technique is common and associated with high success rate.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Classical methods for nerve localization (loss of resistance, cause of paresthesias, nerve
      stimulation technique)assumed that the target is a close approximation to the nerve, without
      epineural perforation. Intraneural injections were considered as evitable, with high risk for
      nerve damages.

      Ultrasound guidance provided for the first time a real-time visualization of the spread of
      local anesthetic. Some recent studies proved, that an intraneural injection using nerve
      stimulator technique is common and not necessarily accompanied with nerve damages.

      In the ultrasound group (group US) the investigators tested the hypothesis, that an
      intraneural injection of local anesthetic generate a high success rate and a short onset time
      without clinical apparent nerve damages.

      In the nerve-stimulation group (group NS) the investigators tested the hypothesis, that an
      intraneural injection of local anesthetic is common, and in case of intraneural injection
      accompanied likewise with high success rate and shorter onset time.

      For the sciatic division the investigators tested the hypothesis, that classical methods of
      nerve localization (nerve-stimulation technique, cause of paresthesias) are not able to avoid
      epineural perforation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Success Rate Without Supplementation</measure>
    <time_frame>within 30-60 minutes after injection of the local anesthetic</time_frame>
    <description>After injection of local anesthetic a waiting period of 30-60 minutes was defined before completing a failed block.
success without supplementation = no additional analgetics or rescue blocks required (success rate without supplementation, outcome measure 1)
success with supplementation = analgetics or selective rescue blocks distal of the sciatic division required (success rate without supplementation and additionally all supplemented blocks, outcome measure 3)
failed block = change of anesthetic procedure (general, spinal) or rescue blocks proximal of the sciatic division</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time Until Readiness for Surgery (Minutes)</measure>
    <time_frame>within 60 minutes after injection of the local anesthetic</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Success Rate With Supplementation</measure>
    <time_frame>later than 30-60 minutes after injection of the local anesthetic</time_frame>
    <description>After injection of local anesthetic a waiting period of 30-60 minutes was defined before completing a failed block.
success without supplementation = no additional analgetics or rescue blocks required (success rate without supplementation, outcome measure 1)
success with supplementation = analgetics or selective rescue blocks distal of the sciatic division required (success rate without supplementation and additionally all supplemented blocks, outcome measure 3)
failed block = change of anesthetic procedure (general, spinal) or rescue blocks proximal of the sciatic divisionSucces rate with supplementation</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">250</enrollment>
  <condition>Other Surgical Procedures</condition>
  <arm_group>
    <arm_group_label>group US</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ultrasound guided block :
20ml Prilocaine 1% and 10ml Ropivacaine 0.75% (30ml Prilocaine 1% in outpatients)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group NS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nerve stimulation technique:
20ml Prilocaine 1% and 10ml Ropivacaine 0.75% (30ml Prilocaine 1% in outpatients)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>midazolam</intervention_name>
    <description>Prior to performing the regional anesthesia the investigators administered midazolam as a premedication by mouth (3,75-7,5mg) or intravenously (2-3mg).</description>
    <arm_group_label>group US</arm_group_label>
    <arm_group_label>group NS</arm_group_label>
    <other_name>Dormicum</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Prilocaine 1%</intervention_name>
    <description>20ml Prilocaine 1% for distal sciatic nerve block (30ml Prilocaine 1% in outpatients)</description>
    <arm_group_label>group US</arm_group_label>
    <arm_group_label>group NS</arm_group_label>
    <other_name>Xylonest</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine 0.75%</intervention_name>
    <description>10ml Ropivacaine 0.75% for distal sciatic nerve block (not in outpatients)</description>
    <arm_group_label>group US</arm_group_label>
    <arm_group_label>group NS</arm_group_label>
    <other_name>Naropin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Prilocaine 1%</intervention_name>
    <description>10ml Prilocaine 1% for saphenous nerve block</description>
    <arm_group_label>group US</arm_group_label>
    <arm_group_label>group NS</arm_group_label>
    <other_name>Xylonest</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ultrasound guidance</intervention_name>
    <description>In group US the sciatic nerve localization and needle guidance is realized using ultrasound.</description>
    <arm_group_label>group US</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>nerve stimulation technique</intervention_name>
    <description>In the group NS sciatic nerve localization and needle guidance is realized using nerve stimulation technique. However, ultrasound is used observing (Observer) the procedure, but blinded for the physician (Anesthetist) performing the block.</description>
    <arm_group_label>group NS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  elective surgery on the foot or ankle

          -  tourniquet distal of the knee

          -  adult patients, 18-75 years old

          -  ASA-risk-groups I-III (American Society of Anesthesiologists)

          -  informed consent

        Exclusion Criteria:

          -  severe coagulopathy

          -  systemic inflammatory response

          -  ASA-risk-groups &gt; III (American Society of Anesthesiologists)

          -  drug allergy: local anesthetics

          -  pregnancy, lactation period

          -  participation in other studies

          -  addiction to drugs or alcohol

          -  non-cooperative patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronald Seidel, Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinik f체r An채sthesiologie und Intensivtherapie, Helios Kliniken Schwerin, Wismarsche Strasse 393-7, DE-19049 Schwerin</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Georg Rehmert, Dr. med.</last_name>
    <role>Study Director</role>
    <affiliation>Klinik f체r An채sthesiologie und Intensivtherapie, Helios Kliniken Schwerin, Wismarsche Strasse 393-7, DE-19049 Schwerin</affiliation>
  </overall_official>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 16, 2012</study_first_submitted>
  <study_first_submitted_qc>July 17, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 18, 2012</study_first_posted>
  <results_first_submitted>March 21, 2013</results_first_submitted>
  <results_first_submitted_qc>August 27, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 1, 2013</results_first_posted>
  <last_update_submitted>August 27, 2013</last_update_submitted>
  <last_update_submitted_qc>August 27, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 1, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Helios Research Center</investigator_affiliation>
    <investigator_full_name>Dr.med.Ronald Seidel</investigator_full_name>
    <investigator_title>Dr.med.Ronald Seidel</investigator_title>
  </responsible_party>
  <keyword>Sciatic Nerve</keyword>
  <keyword>Ultrasound</keyword>
  <keyword>Anesthesia, Regional</keyword>
  <keyword>Orthopedic Surgery</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Prilocaine</mesh_term>
    <mesh_term>Midazolam</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Adult patients were informed and included in the study in the anesthesiology outpatient clinic as part of normal pre-operative preparation. Using a computer-generated list of random numbers, patients were randomly allocated to either the nerve stimulation group (NS group, n=125) or the ultrasound group (US group, n=125).</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Group US</title>
          <description>Ultrasound guided block :
20ml Prilocaine 1% and 10ml Ropivacaine 0.75% (30ml Prilocaine 1% in outpatients)</description>
        </group>
        <group group_id="P2">
          <title>Group NS</title>
          <description>Nerve stimulation technique:
20ml Prilocaine 1% and 10ml Ropivacaine 0.75% (30ml Prilocaine 1% in outpatients)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="125"/>
                <participants group_id="P2" count="125"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="125"/>
                <participants group_id="P2" count="125"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Group US</title>
          <description>Ultrasound guided block :
20ml Prilocaine 1% and 10ml Ropivacaine 0.75% (30ml Prilocaine 1% in outpatients)</description>
        </group>
        <group group_id="B2">
          <title>Group NS</title>
          <description>Nerve stimulation technique:
20ml Prilocaine 1% and 10ml Ropivacaine 0.75% (30ml Prilocaine 1% in outpatients)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="125"/>
            <count group_id="B2" value="125"/>
            <count group_id="B3" value="250"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="99"/>
                    <measurement group_id="B2" value="95"/>
                    <measurement group_id="B3" value="194"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53.4" spread="14.3"/>
                    <measurement group_id="B2" value="56.4" spread="11.8"/>
                    <measurement group_id="B3" value="54.9" spread="13.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="107"/>
                    <measurement group_id="B2" value="91"/>
                    <measurement group_id="B3" value="198"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Germany</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="125"/>
                    <measurement group_id="B2" value="125"/>
                    <measurement group_id="B3" value="250"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Success Rate Without Supplementation</title>
        <description>After injection of local anesthetic a waiting period of 30-60 minutes was defined before completing a failed block.
success without supplementation = no additional analgetics or rescue blocks required (success rate without supplementation, outcome measure 1)
success with supplementation = analgetics or selective rescue blocks distal of the sciatic division required (success rate without supplementation and additionally all supplemented blocks, outcome measure 3)
failed block = change of anesthetic procedure (general, spinal) or rescue blocks proximal of the sciatic division</description>
        <time_frame>within 30-60 minutes after injection of the local anesthetic</time_frame>
        <population>In the NS group two investigators were necessary in order to realize the blinded study protocol. For personnel reasons this was not possible in every case and led to deviations from the randomization protocol for seven patients in each group. These patients were excluded from the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Group US</title>
            <description>Ultrasound guided block :
20ml Prilocaine 1% and 10ml Ropivacaine 0.75% (30ml Prilocaine 1% in outpatients)</description>
          </group>
          <group group_id="O2">
            <title>Group NS</title>
            <description>Nerve stimulation technique:
20ml Prilocaine 1% and 10ml Ropivacaine 0.75% (30ml Prilocaine 1% in outpatients)</description>
          </group>
        </group_list>
        <measure>
          <title>Success Rate Without Supplementation</title>
          <description>After injection of local anesthetic a waiting period of 30-60 minutes was defined before completing a failed block.
success without supplementation = no additional analgetics or rescue blocks required (success rate without supplementation, outcome measure 1)
success with supplementation = analgetics or selective rescue blocks distal of the sciatic division required (success rate without supplementation and additionally all supplemented blocks, outcome measure 3)
failed block = change of anesthetic procedure (general, spinal) or rescue blocks proximal of the sciatic division</description>
          <population>In the NS group two investigators were necessary in order to realize the blinded study protocol. For personnel reasons this was not possible in every case and led to deviations from the randomization protocol for seven patients in each group. These patients were excluded from the analysis.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="118"/>
                <count group_id="O2" value="118"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="112"/>
                    <measurement group_id="O2" value="73"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For sample size calculation we assumed a significance level of 0.05 and a success rate derived from clinical data of 75% in the nerve stimulation group and of 90% in the ultrasound group. With a group ratio of 1:1 and a power of 0.8, the required sample size was at least 226. For statistical analysis we used the exact Fisher test as a distribution-free, non-parametric test method.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt; 0.05</p_value>
            <method>Fisher Exact</method>
            <param_type>Percentage Difference</param_type>
            <param_value>33</param_value>
            <estimate_desc>For success rate without supplementation the difference between group US (94.9%) and group NS (61.9%) is 33%.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Time Until Readiness for Surgery (Minutes)</title>
        <time_frame>within 60 minutes after injection of the local anesthetic</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group US</title>
            <description>Ultrasound guided block :
20ml Prilocaine 1% and 10ml Ropivacaine 0.75% (30ml Prilocaine 1% in outpatients)</description>
          </group>
          <group group_id="O2">
            <title>Group NS</title>
            <description>Nerve stimulation technique:
20ml Prilocaine 1% and 10ml Ropivacaine 0.75% (30ml Prilocaine 1% in outpatients)</description>
          </group>
        </group_list>
        <measure>
          <title>Time Until Readiness for Surgery (Minutes)</title>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="118"/>
                <count group_id="O2" value="118"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.1" lower_limit="13.6" upper_limit="16.5"/>
                    <measurement group_id="O2" value="28" lower_limit="24.9" upper_limit="31.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>We used the log-rank test to compare the onset times. The significance level was defined with p&lt;0.05.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt; 0.05</p_value>
            <method>Log Rank</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>22.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>13.6</ci_lower_limit>
            <ci_upper_limit>31.1</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Success Rate With Supplementation</title>
        <description>After injection of local anesthetic a waiting period of 30-60 minutes was defined before completing a failed block.
success without supplementation = no additional analgetics or rescue blocks required (success rate without supplementation, outcome measure 1)
success with supplementation = analgetics or selective rescue blocks distal of the sciatic division required (success rate without supplementation and additionally all supplemented blocks, outcome measure 3)
failed block = change of anesthetic procedure (general, spinal) or rescue blocks proximal of the sciatic divisionSucces rate with supplementation</description>
        <time_frame>later than 30-60 minutes after injection of the local anesthetic</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group US</title>
            <description>Ultrasound guided block :
20ml Prilocaine 1% and 10ml Ropivacaine 0.75% (30ml Prilocaine 1% in outpatients)</description>
          </group>
          <group group_id="O2">
            <title>Group NS</title>
            <description>Nerve stimulation technique:
20ml Prilocaine 1% and 10ml Ropivacaine 0.75% (30ml Prilocaine 1% in outpatients)</description>
          </group>
        </group_list>
        <measure>
          <title>Success Rate With Supplementation</title>
          <description>After injection of local anesthetic a waiting period of 30-60 minutes was defined before completing a failed block.
success without supplementation = no additional analgetics or rescue blocks required (success rate without supplementation, outcome measure 1)
success with supplementation = analgetics or selective rescue blocks distal of the sciatic division required (success rate without supplementation and additionally all supplemented blocks, outcome measure 3)
failed block = change of anesthetic procedure (general, spinal) or rescue blocks proximal of the sciatic divisionSucces rate with supplementation</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="118"/>
                <count group_id="O2" value="118"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="116"/>
                    <measurement group_id="O2" value="85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>For sample size calculation we assumed a significance level of 0.05 and a success rate derived from clinical data of 75% in the nerve stimulation group and of 90% in the ultrasound group. With a group ratio of 1:1 and a power of 0.8, the required sample size was at least 226. For statistical analysis we used the exact Fisher test as a distribution-free, non-parametric test method.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.05</p_value>
            <method>Fisher Exact</method>
            <param_type>Percentage Difference</param_type>
            <param_value>26.2</param_value>
            <estimate_desc>For success rate with supplementation the difference between group US (98.2%) and group NS (72%) is 26.2%.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Group US</title>
          <description>Ultrasound guided block :
20ml Prilocaine 1% and 10ml Ropivacaine 0.75% (30ml Prilocaine 1% in outpatients)</description>
        </group>
        <group group_id="E2">
          <title>Group NS</title>
          <description>Nerve stimulation technique:
20ml Prilocaine 1% and 10ml Ropivacaine 0.75% (30ml Prilocaine 1% in outpatients)</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="125"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>polyradicular sensomotor impairment</sub_title>
                <description>With one patient in the group NS, the insufficient block was supplemented by spinal anesthesia, which was initially free of complications. In the postoperative course polyradicular sensomotor impairment developed around lumbosacral plexus (L4-S1).</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="125"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="125"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="66" subjects_at_risk="125"/>
                <counts group_id="E2" subjects_affected="24" subjects_at_risk="125"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Paresthesia</sub_title>
                <counts group_id="E1" events="66" subjects_affected="66" subjects_at_risk="125"/>
                <counts group_id="E2" events="24" subjects_affected="24" subjects_at_risk="125"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Ronald Seidel</name_or_title>
      <organization>HELIOS-Kliniken Schwerin, Germany</organization>
      <phone>0049 385 5204251</phone>
      <email>ronald.seidel@helios-kliniken.de</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

